Brandwood Biomedical has established expanded operations in Beijing to support the continuing growth of our client base seeking services in China.
Brandwood Biomedical has a long established presence and reputation for excellence in China regulatory affairs. In order to meet the rapid growth of China services we have expanded into new offices in Beijing via a wholly owned China operating company Brandwood Biomedical (Beijing).
This provides our clients with:
- Direct operational support in China from local Mandarin/English bilingual regulatory experts
- Local license holding services for clients without a direct corporate presence in China.
- Transparency of process – with all contractual arrangements in English and ability for payments in international currencies.
Brandwood Biomedical CEO Arthur Brandwood said “the establishment of our expanded Beijing operations provides a seamless service for our international clients in what is still a rapidly growing market. Healthcare remains a national priority in China and the Medtech market continues to grow at close to 15% a year. This growth is unmatched in any other large markets.”
“Though our local corporate presence, we are able to offer secure and transparent license holding services and deal efficiently with CFDA on our client’s behalf. We aim to take away the regulatory headaches, allowing clients to focus on their commercial priorities.”
Need help in China? Contact us now to discuss your needs and how we can support you.